Tags: US | AVEO | Pharmaceuticals | IPO

AVEO Pharmaceuticals IPO Prices Below Expectations

Friday, 12 Mar 2010 10:44 AM

AVEO Pharmaceuticals Inc.'s initial public offering priced below expectations, resulting in $81 million in proceeds, the biotechnology company said Friday.

AVEO, which develops cancer therapies, sold 9 million shares for $9 apiece. It had hoped to raise about $98 million by selling 7 million shares at between $13 and $15 each.

This year, 11 IPOs have priced below expectations, and only seven have priced within the range initially set by the company and its underwriters. None have priced above.

A volatile stock market and economic worries have made it harder to sell investors on IPOs, which are perceived as riskier than publicly held companies.

AVEO shares are expected to begin trading on the Nasdaq Global Market under the symbol "AVEO" on Friday.

© Copyright 2015 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

1Like our page
2Share
 

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved